Informes retrospectivos sobre el logro y la pérdida de habilidades en el síndrome de Phelan-McDermid

Cristan Farmer1, Ivy Giserman-Kiss1, Ellora Mohanty1

  • 1Cristan Farmer, Ivy Giserman-Kiss, and Ellora Mohanty, Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, National Institutes of Health; Latha Valluripalli Soorya, Department of Psychiatry, Rush University Medical Center; Mustafa Sahin, Department of Neurology, Boston Children's Hospital, Harvard Medical School and Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School; Alexander Kolevzon, Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai and Department of Psychiatry, Icahn School of Medicine at Mount Sinai; Joseph D. Buxbaum, Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai; Department of Psychiatry, Icahn School of Medicine at Mount Sinai; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai; nd Department of Neuroscience, Icahn School of Medicine at Mount Sinai; Elizabeth Berry-Kravis, Departments of Pediatrics, Neurological Sciences, and Anatomy and Cell Biology, Rush University Medical Center; Craig M. Powell, Department of Neurobiology, University of Alabama at Birmingham Heersink School of Medicine and Civitan International Research Center for Neurodevelopmental Disorders, University of Alabama at Birmingham Heersink School of Medicine; Jonathan A. Bernstein, Department of Pediatrics, Stanford University School of Medicine; Audrey Thurm, Neurodevelopmental and Behavioral Phenotyping Service, National Institute of Mental Health, National Institutes of Health.

Resumen

El síndrome de Phelan-McDermid (PMS) es una enfermedad genética rara. Este estudio encontró que las personas con síndrome premenstrual con frecuencia experimentan retrasos significativos y pérdida de habilidades de desarrollo, incluso después de los 10 años.